Email This Press Releases

NASDAQ:RVNC Shareholder Notice: Lawsuit Alleges Securities Laws Violations by Revance Therapeutics, Inc.

An investor, who purchased NASDAQ:RVNC shares, filed a lawsuit against Revance Therapeutics, Inc over alleged violations of Federal Securities Laws.

View full press release

  • We respects your privacy, the information you entered above will not be used to send unsolicited email, and will not be rented or sold to a 3rd party. Your contact information will be shared with the recipient of this message - Privacy Policy